Related Experiment Video
Updated: Sep 19, 2025

In Vitro Assay to Study Tumor-macrophage Interaction
Published on: August 1, 2019
EZH2 regulates tumor-associated macrophages by the KDM6A-mediated inflammatory response in HPV16-positive cervical
Qing Tang1, Ying Yang2, Jia'nan Sun3
1Department of Gynecology, Yantai Yuhuangding Hospital, No.20, Yuhuangding East Road, Yantai, 264000, China.
Abstract:
High-risk HPV subtypes impact the immune response in cervical cancer. Tumor-associated macrophages (TAMs) are well known to contribute to tumor development by regulating the immune response. This study aimed to analyze the mechanism of TAMs by the enhancer of zeste homolog 2 (EZH2) in HPV16+ cervical cancer. The HPV16+ cervical cancer cells, SiHa and CaSki, were treated with increasing concentrations of EZH2 inhibitor EPZ6438 (5, 10, 20, 40, 80 μM) for 24 h. The KDM6A expression is suppressed in a concentration-dependent manner when EZH2 activity is inhibited. Then, the cancer cells were transfected with pcDNA-control or pcDNA-KDM6A, and treated with the IC50 of EPZ6438. The cell viability, levels of IL-6 and CXCL1, and p-Akt(s473)/Akt proteins were measured. The PMA-treated THP-1 cells were induced into M2 macrophages by IL-4 and IL-13. The M2 macrophages were cocultured with the conditioned cancer cells to observe the M2 polarization. In vivo experiments, the effects of EZH2 inhibition on tumor growth were investigated in nude mice. EZH2 inhibition suppressed the cell viability and inflammatory response by suppressing KDM6A in HPV16+ cervical cancer cells. KDM6A overexpression suppressed the effects of EZH2 inhibition on cell viability and inflammatory response. EZH2 inhibition in cancer cells suppressed the M2 macrophages, and its mechanism was related to the KDM6A-mediated inflammatory response. In nude mice models, EZH2 inhibition effectively reduced tumor growth by regulating KDM6A. EZH2 regulated the KDM6A-mediated inflammatory response, thus affecting the polarization of M2 macrophages, leading to tumor growth in HPV16+ cervical cancer. This study provided an insight into the immune modulation of EZH2 in HPV16+ cervical cancer.
Insights
Enhancer of zeste homolog 2 (EZH2) inhibition suppresses tumor growth in HPV16-positive cervical cancer by regulating KDM6A and M2 macrophage polarization. This finding offers insights into immune modulation strategies for cervical cancer treatment.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- High-risk human papillomavirus (HPV) subtypes influence the immune response in cervical cancer.
- Tumor-associated macrophages (TAMs) play a crucial role in tumor development by modulating the immune response.
- The role of enhancer of zeste homolog 2 (EZH2) in TAM-mediated immune regulation within HPV16-positive cervical cancer requires elucidation.
Purpose of the Study:
- To investigate the mechanism by which EZH2 influences TAMs in HPV16-positive cervical cancer.
- To analyze the impact of EZH2 inhibition on KDM6A expression, inflammatory responses, and M2 macrophage polarization in HPV16-positive cervical cancer cells.
- To evaluate the therapeutic potential of EZH2 inhibition in reducing tumor growth in vivo.
Main Methods:
- HPV16-positive cervical cancer cell lines (SiHa, CaSki) were treated with an EZH2 inhibitor (EPZ6438).
- KDM6A expression, cell viability, inflammatory cytokine levels (IL-6, CXCL1), and Akt signaling were assessed.
- M2 macrophage polarization was studied via co-culture experiments, and tumor growth was evaluated in a nude mouse model.
Main Results:
- EZH2 inhibition suppressed cell viability and inflammatory responses by downregulating KDM6A in HPV16-positive cervical cancer cells.
- Overexpression of KDM6A counteracted the effects of EZH2 inhibition on cell viability and inflammation.
- EZH2 inhibition reduced M2 macrophage polarization, linked to KDM6A-mediated inflammatory responses, and decreased tumor growth in vivo.
Conclusions:
- EZH2 inhibition exerts anti-tumor effects in HPV16-positive cervical cancer by suppressing KDM6A and modulating the inflammatory response.
- The mechanism involves KDM6A-mediated regulation of inflammatory pathways, impacting M2 macrophage polarization and subsequent tumor growth.
- EZH2 inhibition represents a potential therapeutic strategy for HPV16-positive cervical cancer through immune modulation.
More Related Videos
Related Concept Videos
The Tumor Microenvironment
Regulation of Angiogenesis and Blood Supply
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

